InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-51.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by GARDNER PHYLLIS, Director. Director active across 1 company, notably Mimedx Group, INC.. Cumulatively, 4 reports have been recorded. History available since 27 May 2021. The latest transaction was disclosed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
35,354 shares@ US$4.9526.5% of flowCommon StockSEC:0001376339-23-000040:0
44,191 shares@ US$3.960.016% mcap36.3% of flowCommon StockSEC:0001376339-22-000091:0
17,056 shares@ US$10.260.014% mcap31.9% of flowCommon StockSEC:0001376339-21-000075:0
17,056 shares@ US$10.2631.9% of flowCommon StockSEC:0001376339-21-000075
4 of 4 declarations
About GARDNER PHYLLIS
Phyllis Gardner is a Director at MIMEDX GROUP, INC. She contributes to the strategic direction of the company and decision-making within the board. MIMEDX GROUP specializes in biomaterials and regenerative therapies. Phyllis Gardner brings valuable expertise in health and life sciences, thereby helping to guide the company's strategy.
